secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vicarious Surgical Inc. (RBOT)
CIK:        0001812173
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0001213900-25-070028
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vicarious Surgical appoints Stephen From as CEO, Adam Sachs becomes President
-----------------------------------------------------------------------------

- Stephen From appointed CEO effective Aug 7, 2025; also joins Board.
- Co-founder Adam Sachs transitions from CEO to President, remains on Board.
- From receives $500k base salary, 50% target bonus, and 297,600-share option grant.
- From previously CEO of Aruna Bio and Kiora Pharmaceuticals; 20+ yrs healthcare leadership.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812173/000121390025070028/0001213900-25-070028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812173/000121390025070028/ea0251051-8k_vicarious.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-070028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer